title: Thirty years of treating HIV-1 infection: where next?
authors.affiliation: Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford, UK; Institute for Emerging Infections, The Oxford Martin School, Oxford, UK; Oxford National Institute of Health Research Biomedical Research Centre, Oxford, UK john.frater@ndm.ox.ac.uk.
authors.forename: John
authors.initials: J
authors.lastname: Frater
mesh_terms: D019380:Anti-HIV Agents / Q000266:history / Q000627:therapeutic use*; D015658:HIV Infections / Q000453:epidemiology / Q000266:history / Q000517:prevention & control*; D015497:HIV-1 / Q000472:pathogenicity*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D065129:Pre-Exposure Prophylaxis / Q000639:trends*; D011315:Preventive Medicine / Q000266:history / Q000639:trends*; D017735:Virus Latency / Q000187:drug effects*
chemical_list: D019380:Anti-HIV Agents
keywords: AIDS; ART; Antiretroviral therapy; HIV